Bio-Rad Laboratories, Inc. (NYSE:BIO) agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) for $100 million on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
174.2 PLN | +2.59% | +3.44% | -11.12% |
1st Jan change | Capi. | |
---|---|---|
-11.12% | 118M | |
-40.86% | 8.27B | |
+0.07% | 3.35B | |
+0.25% | 2.34B | |
-19.81% | 2.02B | |
-22.17% | 1.62B | |
+31.22% | 1.16B | |
-7.21% | 713M | |
+16.67% | 696M | |
-34.59% | 488M |
- Stock Market
- Equities
- SCP Stock
- News Scope Fluidics S.A.
- Bio-Rad Laboratories, Inc. agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for $100 million.